Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 22;11(3):509.
doi: 10.3390/vaccines11030509.

Molecular Determinants of the Early Life Immune Response to COVID-19 Infection and Immunization

Elisabeth M S Beijnen  1   2 , Oludare A Odumade  1   2   3 , Simon D van Haren  1   2
Affiliations
Review

Molecular Determinants of the Early Life Immune Response to COVID-19 Infection and Immunization

Elisabeth M S Beijnen et al. Vaccines (Basel). .

Abstract

Clinical manifestations from primary COVID infection in children are generally less severe as compared to adults, and severe pediatric cases occur predominantly in children with underlying medical conditions. However, despite the lower incidence of disease severity, the burden of COVID-19 in children is not negligible. Throughout the course of the pandemic, the case incidence in children has substantially increased, with estimated cumulative rates of SARS-CoV-2 infection and COVID-19 symptomatic illness in children comparable to those in adults. Vaccination is a key approach to enhance immunogenicity and protection against SARS-CoV-2. Although the immune system of children is functionally distinct from that of other age groups, vaccine development specific for the pediatric population has mostly been limited to dose-titration of formulations that were developed primarily for adults. In this review, we summarize the literature pertaining to age-specific differences in COVID-19 pathogenesis and clinical manifestation. In addition, we review molecular distinctions in how the early life immune system responds to infection and vaccination. Finally, we discuss recent advances in development of pediatric COVID-19 vaccines and provide future directions for basic and translational research in this area.

Keywords: COVID-19; children; infection; vaccine.

PubMed Disclaimer

Conflict of interest statement

S.D.v.H. is named inventor on patents describing early life vaccine adjuvant compositions. E.M.S.B. and O.A.O. declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
A PRISMA diagram illustrating the criteria for inclusion of original research publications that were included in the narrative synthesis of this review.
Figure 2
Figure 2
Expression of molecular and immunological determinants related to viral entry and disease outcome in COVID-19 in children and adults. MIS-C: Multisystem Inflammatory Syndrome in Children. Airway epithelium was depicted containing ciliated cells (brown), goblet cell (green), basal cells (pink), and club cells (blue). Image was created with Biorender.com (accessed on 14 February 2023).
See this image and copyright information in PMC

References

    1. Lotfi M., Hamblin M.R., Rezaei N. COVID-19: Transmission, Prevention, and Potential Therapeutic Opportunities. Clin. Chim. Acta. 2020;508:254–266. doi: 10.1016/j.cca.2020.05.044. - DOI - PMC - PubMed
    1. Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuinness L., Clarke E.L., Wade R.G. The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries. PLoS ONE. 2020;15:e0234765. doi: 10.1371/journal.pone.0234765. - DOI - PMC - PubMed
    1. Kompaniyets L., Agathis N.T., Nelson J.M., Preston L.E., Ko J.Y., Belay B., Pennington A.F., Danielson M.L., DeSisto C.L., Chevinsky J.R., et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA Netw. Open. 2021;4:e2111182. doi: 10.1001/jamanetworkopen.2021.11182. - DOI - PMC - PubMed
    1. Shi T., Pan J., Katikireddi S.V., McCowan C., Kerr S., Agrawal U., Shah S.A., Simpson C.R., Ritchie L.D., Robertson C., et al. Risk of COVID-19 Hospital Admission among Children Aged 5–17 Years with Asthma in Scotland: A National Incident Cohort Study. Lancet Respir. Med. 2021;10:P191–P198. doi: 10.1016/S2213-2600(21)00491-4. - DOI - PMC - PubMed
    1. CDC Estimated COVID-19 Burden. [(accessed on 14 December 2021)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/burden.html.

LinkOut - more resources